Can a simple drug save more donor kidneys from failing?
NCT ID NCT03646344
First seen Nov 17, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This study tested whether the drug heme arginate could help transplanted kidneys start working right away, instead of being delayed. It included 47 adults receiving a deceased-donor kidney transplant. Participants got either heme arginate or a placebo (salt water) at the time of transplant and again 24 hours later. The trial was stopped early, so results are limited, but early findings suggested the drug might reduce kidney injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL TRANSPLANT FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh
Edinburgh, EH16 4UX, United Kingdom
-
NHS Lothian - Royal Infirmary of Edinburgh
Edinburgh, Lothian, EH16 4SA, United Kingdom
Conditions
Explore the condition pages connected to this study.